Numinus Wellness Inc. (OTCMKTS:NUMIF – Get Free Report) saw a large growth in short interest in January. As of January 15th, there was short interest totaling 796,204 shares, a growth of 39.5% from the December 31st total of 570,851 shares. Based on an average trading volume of 143,881 shares, the short-interest ratio is currently 5.5 days. Based on an average trading volume of 143,881 shares, the short-interest ratio is currently 5.5 days.
Numinus Wellness Price Performance
OTCMKTS:NUMIF opened at C$0.03 on Friday. The business’s fifty day moving average price is C$0.04 and its 200 day moving average price is C$0.04. Numinus Wellness has a 12 month low of C$0.01 and a 12 month high of C$0.06.
About Numinus Wellness
Numinus Wellness Inc is a Canada-based company focused on the development and delivery of psychedelic-assisted therapies and mental health services. The company operates a network of wellness clinics across several provinces, offering guided psilocybin-assisted therapy sessions under Health Canada’s regulatory framework. Numinus integrates psychological support, medical oversight and integration counselling to address a range of mental health conditions, including depression, anxiety and post-traumatic stress disorder.
Through its Numinus Bioscience division, the company conducts research and development activities in psychedelic compounds such as psilocybin and other novel molecules.
See Also
- Five stocks we like better than Numinus Wellness
- Stock market legend warns: “An Ominous Day Is Coming for the Markets…”
- Another reason you need to own gold… [running out]
- Trump’s Final Shocking Act Begins February 24
- NEW: Gold makes history
- Deutsche Bank Just Raised Their Gold Target to $6,000
Receive News & Ratings for Numinus Wellness Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Numinus Wellness and related companies with MarketBeat.com's FREE daily email newsletter.
